Canada’s Intellectual Property Firm

Health Canada publishes updated guidance document on classification of products at the device-drug interface

On February 7, 2018, Health Canada published an update to the guidance document Classification of Products at the (Medical) Device-Drug Interface. According to Health Canada’s notice, the update is “intended to reflect the changes to the definition of (medical) device made to the Food and Drugs Act (the Act) following the enactment of the Protecting Canadians from Unsafe Drugs Act (Vanessa’s Law) on November 6, 2014, and to bring greater clarity to the description of how Health Canada classifies health products at the device-drug interface.”